HomeLaboratoryImmunology

Immunology

Enter your email above to receive messages about offerings by Informa, its brands, affiliates and/or third-party partners, consistent with Informa's Privacy Statement.

Leave this field blank

Multi-Drugs Resistant Organisms: Alarming Threat for Infectious Disease Management

Jan 16, 2020

Infectious diseases are illness involving two organisms: a human being as a host and a microorganism as a causative agent. To manage infectious diseases doctors must consider both, otherwise it will not address all the biological characteristics...

Diagnosis of coeliac disease: moving beyond biopsy

Jan 16, 2020

Serological tests nowadays form the backbone of coeliac disease (CD) diagnostics, with biopsy increasingly relegated to a confirmatory role and used only to clarify difficult cases. Official diagnostic criteria are based primarily on the detection...

Antibiotic Resistance: An Impending Health Crisis

Jan 16, 2020

Antibiotics Use and Misuse, a new conference track at MEDLAB 2018, featured engaging expert-led sessions that discussed the latest developments, innovations, and the corrections necessary to meet the critical need of tackling antibiotic misuse

The clinical use of Ret-He in the differential diagnosis of anaemia

Jan 16, 2020

Anaemia is a global public health problem affecting populations in both developing and developed countries. According to the World Health Organization (WHO) anaemia affects 1.62 billion people, which corresponds to 25% of the world population. It...

Need of the Hour – Addressing the Challenges of Multi-drug Resistance of Hospital Acquired Infections and the Role of the Laboratory in Lowering the Infection Rates

Jan 15, 2020

LACK OF NEW DRUGS TO COMBAT THE INFECTIOUS AGENTS THAT ARE BECOMING INCREASINGLY RESISTANT TO EXISTING DRUGS IS A SERIOUS CAUSE FOR CONCERN

Power of cancer immunotherapy expanded by improved antigen presentation

Jan 13, 2020

Cancer immunotherapy—an approach that removes the barriers that protect cancer cells from a patient’s immune system—has revolutionised the treatment of many cancer types. About 40 per cent of melanoma patients, for example, respond to...